Next Article in Journal
ABCC6 and Pseudoxanthoma Elasticum: The Face of a Rare Disease from Genetics to Advocacy
Next Article in Special Issue
Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia
Previous Article in Journal
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease
Previous Article in Special Issue
Semi-Quantitative Mass Spectrometry in AML Cells Identifies New Non-Genomic Targets of the EZH2 Methyltransferase
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 18
Issue 7
10.3390/ijms18071492
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy

by
Justin M. Watts
1,†,
Aymee Perez
1,†,
Lutecia Pereira
1,
Yao-Shan Fan
2,
Geoffrey Brown
3,4,
Francisco Vega
2,
Kevin Petrie
5,*,
Ronan T. Swords
1 and
Arthur Zelent
1,*
1
Division of Hematology/Oncology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
2
Department of Pathology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
3
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK
4
Institute of Clinical Sciences, University of Birmingham, Birmingham B15 2TT, UK
5
Faculty of Natural Sciences, University of Stirling, Stirling FK9 4LA, UK
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this study.
Int. J. Mol. Sci. 2017, 18(7), 1492; https://doi.org/10.3390/ijms18071492
Submission received: 6 June 2017 / Revised: 4 July 2017 / Accepted: 5 July 2017 / Published: 11 July 2017
(This article belongs to the Special Issue The Biology and Treatment of Myeloid Leukaemias)
Browse Figures
Versions Notes

Abstract

Here we report the case of a 30-year-old woman with relapsed acute myeloid leukemia (AML) who was treated with all-trans retinoic acid (ATRA) as part of investigational therapy (NCT02273102). The patient died from rapid disease progression following eight days of continuous treatment with ATRA. Karyotype analysis and RNA-Seq revealed the presence of a novel t(4;15)(q31;q22) reciprocal translocation involving the TMEM154 and RASGRF1 genes. Analysis of primary cells from the patient revealed the expression of TMEM154-RASGRF1 mRNA and the resulting fusion protein, but no expression of the reciprocal RASGRF1-TMEM154 fusion. Consistent with the response of the patient to ATRA therapy, we observed a rapid proliferation of t(4;15) primary cells following ATRA treatment ex vivo. Preliminary characterization of the retinoid response of t(4;15) AML revealed that in stark contrast to non-t(4;15) AML, these cells proliferate in response to specific agonists of RARα and RARγ. Furthermore, we observed an increase in the levels of nuclear RARγ upon ATRA treatment. In summary, the identification of the novel t(4;15)(q31;q22) reciprocal translocation opens new avenues in the study of retinoid resistance and provides potential for a new biomarker for therapy of AML.
Keywords: acute myeloid leukemia; t(4; 15)(q31; q22); TMEM154-RASGRF1; ATRA; retinoid; NCT02273102 acute myeloid leukemia; t(4; 15)(q31; q22); TMEM154-RASGRF1; ATRA; retinoid; NCT02273102
Graphical Abstract

Share and Cite

MDPI and ACS Style

Watts, J.M.; Perez, A.; Pereira, L.; Fan, Y.-S.; Brown, G.; Vega, F.; Petrie, K.; Swords, R.T.; Zelent, A. A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy. Int. J. Mol. Sci. 2017, 18, 1492. https://doi.org/10.3390/ijms18071492

AMA Style

Watts JM, Perez A, Pereira L, Fan Y-S, Brown G, Vega F, Petrie K, Swords RT, Zelent A. A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy. International Journal of Molecular Sciences. 2017; 18(7):1492. https://doi.org/10.3390/ijms18071492

Chicago/Turabian Style

Watts, Justin M., Aymee Perez, Lutecia Pereira, Yao-Shan Fan, Geoffrey Brown, Francisco Vega, Kevin Petrie, Ronan T. Swords, and Arthur Zelent. 2017. "A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy" International Journal of Molecular Sciences 18, no. 7: 1492. https://doi.org/10.3390/ijms18071492

APA Style

Watts, J. M., Perez, A., Pereira, L., Fan, Y.-S., Brown, G., Vega, F., Petrie, K., Swords, R. T., & Zelent, A. (2017). A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy. International Journal of Molecular Sciences, 18(7), 1492. https://doi.org/10.3390/ijms18071492

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop